Results

Total Results: 5,692 records

Showing results for "venous".

  1. Appendix C (pdf file)

    hcup-us.ahrq.gov/reports/natstats/his95/appendc.pdf
    February 11, 2011 - thrombophlebitis - 4510 45111 45119 4512 45181 45182 45183 45184 45189 4519 V1252 7.5.1.2 Other venous
  2. hcup-us.ahrq.gov/reports/natstats/his96/table2.pdf
    February 11, 2011 - catheterization 7,422 0.02 $29,814 $4,150 $12,048 $30,369 12.3 3.3 53.3 0.3 7.12.3 Venous
  3. digital.ahrq.gov/sites/default/files/docs/citation/r21hs028563-final-report-galarraga-2023.pdf
    January 01, 2023 - heart rate, higher temperature, higher creatinine, lower lymphocytes, lower platelets, and lower pCO2 venous
  4. hcup-us.ahrq.gov/news/exhibit_booth/hcup_90_min_pres.jsp
    December 01, 2022 - therapeutic reasons 0210093, Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous
  5. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/carotid-artery-stenosis-screening
    July 08, 2014 - permanent cranial nerve damage, pulmonary embolism, pneumonia, wound infection, acute renal failure, deep venous
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - Examples of the latter include venous thromboembolism risk in women taking third generation over-the-counter
  7. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-fullreport.pdf
    July 01, 2016 - The risk of venous thromboembolism for each obese woman should be evaluated.
  8. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-fullreport.pdf
    July 01, 2016 - The risk of venous thromboembolism for each obese woman should be evaluated.
  9. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-fullreport.pdf
    July 01, 2016 - The risk of venous thromboembolism for each obese woman should be evaluated.
  10. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-fullreport.pdf
    July 01, 2016 - The risk of venous thromboembolism for each obese woman should be evaluated.
  11. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-fullreport.pdf
    July 01, 2016 - The risk of venous thromboembolism for each obese woman should be evaluated.
  12. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-fullreport.pdf
    July 01, 2016 - The risk of venous thromboembolism for each obese woman should be evaluated.
  13. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Hook_25.pdf
    February 26, 2008 - that the KBNI process has been used for other topics, such as delirium, activity intolerance, and venous
  14. effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - versus placebo, the association of treatment group with risk of coronary heart disease, stroke, or venous
  15. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - Examples of the latter include venous thromboembolism risk in women taking third generation over-the-counter
  16. effectivehealthcare.ahrq.gov/products/heart-failure-natriuretic-peptide/research-protocol
    December 20, 2011 - breathlessness, fatigue, ankle swelling), and signs (tachycardia, tachypnea, rales, increased jugular venous
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - hemangioma and vertebral hemangioma are usually a misnomer due to issues with terminology, and actually venous
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - versus placebo, the association of treatment group with risk of coronary heart disease, stroke, or venous
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - versus placebo, the association of treatment group with risk of coronary heart disease, stroke, or venous
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - hemangioma and vertebral hemangioma are usually a misnomer due to issues with terminology, and actually venous